购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

GSK 3 Inhibitor IX

产品编号 T1917Cas号 667463-62-9
别名 MLS 2052, GSK 3 IX, BIO, 6-bromoindirubin-3-oxime, 6-Bromoindirubin-3'-oxime, 6-BIO

GSK 3 Inhibitor IX (6-BIO) 是一种选择性可逆的,ATP 竞争性的 GSK-3α/β和 CDK1-cyclinB 复合体抑制剂,能够抑制 (GSK-3α/β)/CDK1/CDK5 的活性,IC50值分别为 5 nM/320 nM/83 nM。

GSK 3 Inhibitor IX
TargetMol

为众多的药物研发团队赋能,

让新药发现更简单!

GSK 3 Inhibitor IX

纯度: 99.72%
产品编号 T1917 别名 MLS 2052, GSK 3 IX, BIO, 6-bromoindirubin-3-oxime, 6-Bromoindirubin-3'-oxime, 6-BIOCas号 667463-62-9

GSK 3 Inhibitor IX (6-BIO) 是一种选择性可逆的,ATP 竞争性的 GSK-3α/β和 CDK1-cyclinB 复合体抑制剂,能够抑制 (GSK-3α/β)/CDK1/CDK5 的活性,IC50值分别为 5 nM/320 nM/83 nM。

规格价格库存数量
1 mg¥ 258现货
2 mg¥ 362现货
5 mg¥ 651现货
10 mg¥ 897现货
25 mg¥ 1,960现货
50 mg¥ 3,570现货
100 mg¥ 5,160现货
500 mg¥ 10,800现货
1 mL x 10 mM (in DMSO)¥ 719现货
大包装 & 定制
加入购物车
实验操作小课堂
查看更多

"GSK 3 Inhibitor IX"的相关化合物库

选择批次:
纯度:99.72%
联系我们获取更多批次信息
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

产品介绍

生物活性
产品描述
GSK 3 Inhibitor IX (6-BIO) is a selective reversible, ATP-competitive inhibitor of GSK-3α/β and CDK1-cyclinB complex. It inhibits (GSK-3α/β)/CDK1/CDK5 activity with IC50 values of 5 nM/320 nM/83 nM, respectively.
靶点活性
CDK5-p35:0.08 μM, TYK2:30 nM, CDK2-CyclinA:0.30 μM, CDK1-CyclinB:0.32 μM, GSK-3:5 nM
体外活性
BIO抑制小鼠移植瘤模型中黑色素瘤生长.
体内活性
BIO是pan-JAK抑制剂,作用于TYK2,JAK1,JAK2 和 JAK3,IC50值分别为0.03,1.5,8.0,0.5 μM。BIO是糖原合成酶激酶-3(GSK-3)的特异性抑制剂,GSK-3α/β的IC50为5 nM,比CDK5选择性高16倍以上。BIO与这些激酶的ATP结合口袋相互作用,减少细胞模型中GSK-3特异性位点上的β-连环蛋白磷酸化。BIO促进哺乳动物心肌细胞增殖。BIO选择性抑制STAT3磷酸化,并诱导人类黑色素瘤细胞凋亡。在人类和小鼠胚胎干细胞中,BIO维持未分化表型并维持多能状态特异性转录因子Oct-3/4,Rex-1和Nanog的表达。
激酶实验
Kinase assay: Kinase activities are assayed in Buffer A or C at 30°C, at a final ATP concentration of 15 μM. Blank values are subtracted and activities calculated as pmoles of phosphate incorporated during a 10 min incubation. Controls are performed with appropriate dilutions of dimethylsulfoxide. In a few cases phosphorylation of the substrate is assessed by autoradiography after SDS-PAGE. GSK-3α/β is purified from porcine brain by affinity chromatography on immobilized axin. It is assayed, following a 1/100 dilution in 1 mg BSA/ml 10 mM DTT, with 5 μl 40 μM GS-1 peptide, a specific GSK-3 substrate, (YRRAAVPPSPSLSRHSSPHQSpEDEEE), in buffer A, in the presence of 15 μM [γ-32P] ATP (3,000 Ci/mmol; 1 mCi/ml) in a final volume of 30 μl. After 30 min incubation at 30°C, 25 μl aliquots of supernatant are spotted onto 2.5 × 3 cm pieces of Whatman P81 phosphocellulose paper, and 20 seconds later, the filters are washed five times (for at least 5 min each time) in a solution of 10 ml phosphoric acid/liter of water. The wet filters are counted in the presence of 1 ml ACS scintillation fluid.
细胞实验
COS1, Hepa (wild-type, CEM/LM AhR deficient and ELB1 ARNT deficient), or SH-SY5Y cells are grown in 6 cm culture dishes in Dulbecco's Modified Medium (DMEM) containing 10% fetal bovine serum. For treatment, IO (5 μM), BIO (5 or 10 μM), MeBIO (5 or 50 μM), LiCl (20 or 40 mM), or mock solution (DMSO, 0.5% final concentration) is added to medium when cell density reaches ~70% confluence. After 12 (SH-SY5Y) or 24 hours, the cells, while still in plate, are lysed with lysis buffer (1% SDS, 1 mM sodium orthovanadate, 10 mM Tris [pH 7.4]). The lysate is passed several times through a 26 g needle, centrifuged at 10,000 × g for 5 min, and adjusted to equal protein concentration. About 8 μg of each sample is loaded for immunoblotting. Enhanced chemiluminescence is used for detection. The following primary antibodies are used: mouse anti-β-catenin CT (Upstate Biotechnolgies, Clone 7D8, recognizes total β-catenin), mouse anti-phospho-β-catenin (Upstate Biotechnologies, Clone 8E7, recognizes dephosphorylated β-catenin), mouse anti-GSK-3 β, mouse anti-GSK-3 phosphoTyr216, rabbit anti-AhR (Aryl hydrocarbon receptor), and rabbit anti-actin.(Only for Reference)
别名MLS 2052, GSK 3 IX, BIO, 6-bromoindirubin-3-oxime, 6-Bromoindirubin-3'-oxime, 6-BIO
化学信息
分子量356.17
分子式C16H10BrN3O2
CAS No.667463-62-9
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度信息
DMSO: 45 mg/mL (126.34 mM)
Ethanol: 21 mg/mL (58.96 mM)
溶液配制表
Ethanol/DMSO
1mg5mg10mg50mg
1 mM2.8076 mL14.0382 mL28.0765 mL140.3824 mL
5 mM0.5615 mL2.8076 mL5.6153 mL28.0765 mL
10 mM0.2808 mL1.4038 mL2.8076 mL14.0382 mL
20 mM0.1404 mL0.7019 mL1.4038 mL7.0191 mL
50 mM0.0562 mL0.2808 mL0.5615 mL2.8076 mL
DMSO
1mg5mg10mg50mg
100 mM0.0281 mL0.1404 mL0.2808 mL1.4038 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μLTargetMol | Animal experiments 一共给药动物 10 只 ,您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60% ddH2O. 那么您的工作液浓度为 2 mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween 80, 混匀澄清,再加 600μLddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
%Tween 80
%ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

关键词

Related Tags: buy GSK 3 Inhibitor IX | purchase GSK 3 Inhibitor IX | GSK 3 Inhibitor IX cost | order GSK 3 Inhibitor IX | GSK 3 Inhibitor IX chemical structure | GSK 3 Inhibitor IX in vivo | GSK 3 Inhibitor IX in vitro | GSK 3 Inhibitor IX formula | GSK 3 Inhibitor IX molecular weight